Sightline Wealth Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-14,958
Closed -$38K 59
2021
Q3
$38K Buy
+14,958
New +$38K 0.03% 53